Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders

被引:90
作者
Frishberg, Y
Topaz, O
Bergman, R
Behar, D
Fisher, D
Gordon, D
Richard, G
Sprecher, E [1 ]
机构
[1] Rambam Med Ctr, Lab Mol Dermatol, Haifa, Israel
[2] Rambam Med Ctr, Dept Dermatol, Haifa, Israel
[3] Shaare Zedek Med Ctr, Div Pediat Nephrol, Jerusalem, Israel
[4] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[5] Shaare Zedek Med Ctr, Dept Radiol, Jerusalem, Israel
[6] Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA
[7] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2005年 / 83卷 / 01期
关键词
calcinosis; phosphate; hyperostosis; proximal tubule;
D O I
10.1007/s00109-004-0610-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hyperphosphatemia-hyperostosis syndrome (HHS) is a rare autosomal recessive metabolic disorder characterized by elevated serum phosphate levels and repeated attacks of acute, painful swellings of the long bones with radiological evidence of periosteal reaction and cortical hyperostosis. HHS shares several clinical and metabolic features with hyperphosphatemic familial tumoral calcinosis (HFTC), which is caused by mutations in GALNT3 encoding a glycosyltransferase responsible for initiating O-glycosylation. To determine whether GALNT3 is involved in the pathogenesis of HHS we screened two unrelated Arab-Israeli HHS families for pathogenic mutations in this gene. All affected individuals harbored a homozygous splice site mutation (1524+IG -> A) in GALNT3. This mutation was previously described in a large Druze HFTC kindred and has been shown to alter GALNT3 expression and result in ppGalNAc-T3 deficiency. Genotype analysis of six microsatellite markers across the GALNT3 region on 2q24-q31 revealed that the HHS and HFTC families share a common haplotype spanning approximately 0.14 Mb. Our results demonstrate that HHS and HFTC are allelic disorders despite their phenotypic differences and suggest a common origin of the 1524+1G -> A mutation in the Middle East (founder effect). The heterogeneous phenotypic expression of the identified splice site mutation implies the existence of inherited or epigenetic modifying factors of importance in the regulation of ppGalNAc-T3 activity.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 19 条
[1]   CORTICAL HYPEROSTOSIS WITH HYPERPHOSPHATEMIA [J].
ALTMAN, HS ;
POMERANCE, HH .
JOURNAL OF PEDIATRICS, 1971, 79 (05) :874-+
[2]   TUMORAL CALCINOSIS, DIAPHYSITIS, AND HYPERPHOSPHATEMIA [J].
CLARKE, E ;
SWISCHUK, LE ;
HAYDEN, CK .
RADIOLOGY, 1984, 151 (03) :643-646
[3]  
DANA N, 1997, DRUZES
[4]   A GENE (PEX) WITH HOMOLOGIES TO ENDOPEPTIDASES IS MUTATED IN PATIENTS WITH X-LINKED HYPOPHOSPHATEMIC RICKETS [J].
FRANCIS, F ;
HENNIG, S ;
KORN, B ;
REINHARDT, R ;
DEJONG, P ;
POUSTKA, A ;
LEHRACH, H ;
ROWE, PSN ;
GOULDING, JN ;
SUMMERFIELD, T ;
MOUNTFORD, R ;
READ, AP ;
POPOWSKA, E ;
PRONICKA, E ;
DAVIES, KE ;
ORIORDAN, JLH ;
ECONS, MJ ;
NESBITT, T ;
DREZNER, MK ;
OUDET, C ;
PANNETIER, S ;
HANAUER, A ;
STROM, TM ;
MEINDL, A ;
LORENZ, B ;
CAGNOLI, M ;
MOHNIKE, KL ;
MURKEN, J ;
MEITINGER, T .
NATURE GENETICS, 1995, 11 (02) :130-136
[5]   Estimating the age of mutant disease alleles based on linkage disequilibrium [J].
Guo, SW ;
Xiong, MM .
HUMAN HEREDITY, 1997, 47 (06) :315-337
[6]  
KONG X, 2004, BIOINFORMATICS 0916
[7]   CORTICAL HYPEROSTOSIS WITH HYPERPHOSPHATEMIA - A NEW SYNDROME [J].
MELHEM, RE ;
NAJJAR, SS ;
KHACHADURIAN, AK .
JOURNAL OF PEDIATRICS, 1970, 77 (06) :986-+
[8]   SILVER STAINING OF PROTEINS AND DNA [J].
MERRIL, CR .
NATURE, 1990, 343 (6260) :779-780
[9]   THE SYNDROME OF HYPER-OSTOSIS AND HYPERPHOSPHATEMIA [J].
MIKATI, MA ;
MELHEM, RE ;
NAJJAR, SS .
JOURNAL OF PEDIATRICS, 1981, 99 (06) :900-904
[10]   Hyperostosis with hyperphosphatemia: Evidence of familial occurrence and association with tumoral calcinosis [J].
Narchi, H .
PEDIATRICS, 1997, 99 (05) :745-748